{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:25:37Z","timestamp":1793190337794,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11060-021-03846-z","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T12:02:48Z","timestamp":1631793768000},"page":"265-274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1"],"prefix":"10.1007","volume":"154","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6833-956X","authenticated-orcid":false,"given":"Jordan","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Pesic-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter F. M.","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Morokoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate J.","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Dabscheck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,16]]},"reference":[{"key":"3846_CR1","doi-asserted-by":"publisher","first-page":"9658","DOI":"10.1073\/pnas.88.21.9658","volume":"88","author":"DH Gutmann","year":"1991","unstructured":"Gutmann DH, Wood DL, Collins FS (1991) Identification of the neurofibromatosis type 1 gene product. Proc Natl Acad Sci USA 88:9658\u20139662. https:\/\/doi.org\/10.1073\/pnas.88.21.9658","journal-title":"Proc Natl Acad Sci USA"},{"key":"3846_CR2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152a","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F (2010) Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A 152a:327\u2013332. https:\/\/doi.org\/10.1002\/ajmg.a.33139","journal-title":"Am J Med Genet A"},{"key":"3846_CR3","doi-asserted-by":"publisher","first-page":"17004","DOI":"10.1038\/nrdp.2017.4","volume":"3","author":"DH Gutmann","year":"2017","unstructured":"Gutmann DH, Ferner RE, Listernick RH, Korf BR, Wolters PL, Johnson KJ (2017) Neurofibromatosis type 1. Nat Rev Dis Primers 3:17004. https:\/\/doi.org\/10.1038\/nrdp.2017.4","journal-title":"Nat Rev Dis Primers"},{"key":"3846_CR4","doi-asserted-by":"publisher","first-page":"E1506","DOI":"10.1002\/humu.21271","volume":"31","author":"E Pasmant","year":"2010","unstructured":"Pasmant E, Sabbagh A, Spurlock G, Laurendeau I, Grillo E, Hamel MJ, Martin L, Barbarot S, Leheup B, Rodriguez D, Lacombe D, Dollfus H, Pasquier L, Isidor B, Ferkal S, Soulier J, Sanson M, Dieux-Coeslier A, Bi\u00e8che I, Parfait B, Vidaud M, Wolkenstein P, Upadhyaya M, Vidaud D (2010) NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype. Hum Mutat 31:E1506-1518. https:\/\/doi.org\/10.1002\/humu.21271","journal-title":"Hum Mutat"},{"key":"3846_CR5","doi-asserted-by":"publisher","first-page":"9914","DOI":"10.1073\/pnas.88.22.9914","volume":"88","author":"JE DeClue","year":"1991","unstructured":"DeClue JE, Cohen BD, Lowy DR (1991) Identification and characterization of the neurofibromatosis type 1 protein product. Proc Natl Acad Sci USA 88:9914\u20139918. https:\/\/doi.org\/10.1073\/pnas.88.22.9914","journal-title":"Proc Natl Acad Sci USA"},{"key":"3846_CR6","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2340\/0001555575136140","volume":"75","author":"M Z\u00f6ller","year":"1995","unstructured":"Z\u00f6ller M, Rembeck B, Akesson HO, Angervall L (1995) Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in G\u00f6teborg. Sweden Acta Derm Venereol 75:136\u2013140. https:\/\/doi.org\/10.2340\/0001555575136140","journal-title":"Sweden Acta Derm Venereol"},{"key":"3846_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/1098-2272(200101)20:1<75::AID-GEPI7>3.0.CO;2-Z","volume":"20","author":"GE Airewele","year":"2001","unstructured":"Airewele GE, Sigurdson AJ, Wiley KJ, Frieden BE, Caldarera LW, Riccardi VM, Lewis RA, Chintagumpala MM, Ater JL, Plon SE, Bondy ML (2001) Neoplasms in neurofibromatosis 1 are related to gender but not to family history of cancer. Genet Epidemiol 20:75\u201386","journal-title":"Genet Epidemiol"},{"key":"3846_CR8","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1158\/1078-0432.CCR-08-0086","volume":"14","author":"C Mussi","year":"2008","unstructured":"Mussi C, Schildhaus H-U, Gronchi A, Wardelmann E, Hohenberger P (2008) Therapeutic consequences from molecular biology for gastrointestinal stromal tumor patients affected by neurofibromatosis type 1. Clin Cancer Res 14:4550. https:\/\/doi.org\/10.1158\/1078-0432.CCR-08-0086","journal-title":"Clin Cancer Res"},{"key":"3846_CR9","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DG Evans","year":"2002","unstructured":"Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311\u2013314. https:\/\/doi.org\/10.1136\/jmg.39.5.311","journal-title":"J Med Genet"},{"key":"3846_CR10","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-1-59745-510-7_2","volume-title":"The genetics and molecular biology of neural tumours","author":"A Sandberg","year":"2008","unstructured":"Sandberg A, Stone J (2008) Malignant peripheral nerve sheath tumours. The genetics and molecular biology of neural tumours. Humana Press, Totowa, pp 43\u201381"},{"key":"3846_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1079>3.0.CO;2-5","volume":"30","author":"RA Lothe","year":"2001","unstructured":"Lothe RA, Smith-Sorensen B, Hektoen M, Stenwig AE, Mandahl N, Saeter G, Mertens F (2001) Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors. Genes Chromosom Cancer 30:202\u2013206","journal-title":"Genes Chromosom Cancer"},{"key":"3846_CR12","doi-asserted-by":"publisher","first-page":"i50","DOI":"10.1093\/noajnl\/vdz049","volume":"2","author":"A Pemov","year":"2020","unstructured":"Pemov A, Li H, Presley W, Wallace MR, Miller DT (2020) Genetics of human malignant peripheral nerve sheath tumors. Neurooncol Adv 2:i50\u2013i61. https:\/\/doi.org\/10.1093\/noajnl\/vdz049","journal-title":"Neurooncol Adv"},{"key":"3846_CR13","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1002\/path.2494","volume":"217","author":"I Bottillo","year":"2009","unstructured":"Bottillo I, Ahlquist T, Brekke H, Danielsen SA, van den Berg E, Mertens F, Lothe RA, Dallapiccola B (2009) Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours. J Pathol 217:693\u2013701. https:\/\/doi.org\/10.1002\/path.2494","journal-title":"J Pathol"},{"key":"3846_CR14","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/ng.3095","volume":"46","author":"W Lee","year":"2014","unstructured":"Lee W, Teckie S, Wiesner T, Ran L, Prieto Granada CN, Lin M, Zhu S, Cao Z, Liang Y, Sboner A, Tap WD, Fletcher JA, Huberman KH, Qin LX, Viale A, Singer S, Zheng D, Berger MF, Chen Y, Antonescu CR, Chi P (2014) PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet 46:1227\u20131232. https:\/\/doi.org\/10.1038\/ng.3095","journal-title":"Nat Genet"},{"key":"3846_CR15","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1158\/1541-7786.MCR-19-0147","volume":"17","author":"J Korfhage","year":"2019","unstructured":"Korfhage J, Lombard DB (2019) Malignant peripheral nerve sheath tumors: from epigenome to bedside. Mol Cancer Res 17:1417\u20131428","journal-title":"Mol Cancer Res"},{"key":"3846_CR16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/modpathol.2016.103","volume":"29","author":"AH Cleven","year":"2016","unstructured":"Cleven AH, Al Sannaa GA, Briaire-de Bruijn I, Ingram DR, van de Rijn M, Rubin BP, de Vries MW, Watson KL, Torres KE, Wang WL, van Duinen SG, Hogendoorn PC, Lazar AJ, Bovee JV (2016) Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol 29:1113. https:\/\/doi.org\/10.1038\/modpathol.2016.103","journal-title":"Mod Pathol"},{"key":"3846_CR17","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1038\/ng.3116","volume":"46","author":"M Zhang","year":"2014","unstructured":"Zhang M, Wang Y, Jones S, Sausen M, McMahon K, Sharma R, Wang Q, Belzberg AJ, Chaichana K, Gallia GL, Gokaslan ZL, Riggins GJ, Wolinksy JP, Wood LD, Montgomery EA, Hruban RH, Kinzler KW, Papadopoulos N, Vogelstein B, Bettegowda C (2014) Somatic mutations of SUZ12 in malignant peripheral nerve sheath tumors. Nat Genet 46:1170\u20131172. https:\/\/doi.org\/10.1038\/ng.3116","journal-title":"Nat Genet"},{"key":"3846_CR18","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/nature13561","volume":"514","author":"T De Raedt","year":"2014","unstructured":"De Raedt T, Beert E, Pasmant E, Luscan A, Brems H, Ortonne N, Helin K, Hornick JL, Mautner V, Kehrer-Sawatzki H, Clapp W, Bradner J, Vidaud M, Upadhyaya M, Legius E, Cichowski K (2014) PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature 514:247\u2013251. https:\/\/doi.org\/10.1038\/nature13561","journal-title":"Nature"},{"key":"3846_CR19","doi-asserted-by":"publisher","first-page":"14992","DOI":"10.1038\/s41598-017-15183-1","volume":"7","author":"AS Brohl","year":"2017","unstructured":"Brohl AS, Kahen E, Yoder SJ, Teer JK, Reed DR (2017) The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation. Sci Rep 7:14992. https:\/\/doi.org\/10.1038\/s41598-017-15183-1","journal-title":"Sci Rep"},{"key":"3846_CR20","first-page":"241","volume":"142","author":"P Mandel","year":"1948","unstructured":"Mandel P, Metais P (1948) Nuclear acids in human blood plasma. CR Seances Soc Biol Fil 142:241\u2013243","journal-title":"CR Seances Soc Biol Fil"},{"key":"3846_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nrc.2017.7","volume":"17","author":"JCM Wan","year":"2017","unstructured":"Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N (2017) Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer 17:223\u2013238. https:\/\/doi.org\/10.1038\/nrc.2017.7","journal-title":"Nat Rev Cancer"},{"key":"3846_CR22","first-page":"67","volume":"3","author":"GD Sorenson","year":"1994","unstructured":"Sorenson GD, Pribish DM, Valone FH, Memoli VA, Bzik DJ, Yao SL (1994) Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomark Prev 3:67\u201371","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"3846_CR23","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DS, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11:426\u2013437. https:\/\/doi.org\/10.1038\/nrc3066","journal-title":"Nat Rev Cancer"},{"key":"3846_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3007094","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong SM, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih LM, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang TL, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA Jr (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3007094","journal-title":"Sci Transl Med"},{"key":"3846_CR25","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm.3519","volume":"20","author":"AM Newman","year":"2014","unstructured":"Newman AM, Bratman SV, To J, Wynne JF, Eclov NC, Modlin LA, Liu CL, Neal JW, Wakelee HA, Merritt RE, Shrager JB, Loo BW Jr, Alizadeh AA, Diehn M (2014) An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med 20:548\u2013554. https:\/\/doi.org\/10.1038\/nm.3519","journal-title":"Nat Med"},{"key":"3846_CR26","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1158\/1078-0432.Ccr-13-2482","volume":"20","author":"GR Oxnard","year":"2014","unstructured":"Oxnard GR, Paweletz CP, Kuang Y, Mach SL, O\u2019Connell A, Messineo MM, Luke JJ, Butaney M, Kirschmeier P, Jackman DM, J\u00e4nne PA (2014) Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin Cancer Res 20:1698\u20131705. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-13-2482","journal-title":"Clin Cancer Res"},{"key":"3846_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","volume":"368","author":"SJ Dawson","year":"2013","unstructured":"Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF, Dunning MJ, Gale D, Forshew T, Mahler-Araujo B, Rajan S, Humphray S, Becq J, Halsall D, Wallis M, Bentley D, Caldas C, Rosenfeld N (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368:1199\u20131209. https:\/\/doi.org\/10.1056\/NEJMoa1213261","journal-title":"N Engl J Med"},{"key":"3846_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature12065","volume":"497","author":"M Murtaza","year":"2013","unstructured":"Murtaza M, Dawson SJ, Tsui DW, Gale D, Forshew T, Piskorz AM, Parkinson C, Chin SF, Kingsbury Z, Wong AS, Marass F, Humphray S, Hadfield J, Bentley D, Chin TM, Brenton JD, Caldas C, Rosenfeld N (2013) Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497:108\u2013112. https:\/\/doi.org\/10.1038\/nature12065","journal-title":"Nature"},{"key":"3846_CR29","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M, Thornton K, Agrawal N, Sokoll L, Szabo SA, Kinzler KW, Vogelstein B, Diaz LA Jr (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14:985\u2013990. https:\/\/doi.org\/10.1038\/nm.1789","journal-title":"Nat Med"},{"key":"3846_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf6219","author":"J Tie","year":"2016","unstructured":"Tie J, Wang Y, Tomasetti C, Li L, Springer S, Kinde I, Silliman N, Tacey M, Wong HL, Christie M, Kosmider S, Skinner I, Wong R, Steel M, Tran B, Desai J, Jones I, Haydon A, Hayes T, Price TJ, Strausberg RL, Diaz LA Jr, Papadopoulos N, Kinzler KW, Vogelstein B, Gibbs P (2016) Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aaf6219","journal-title":"Sci Transl Med"},{"key":"3846_CR31","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/s1470-2045(20)30444-7","volume":"21","author":"NC Turner","year":"2020","unstructured":"Turner NC, Kingston B, Kilburn LS, Kernaghan S, Wardley AM, Macpherson IR, Baird RD, Roylance R, Stephens P, Oikonomidou O, Braybrooke JP, Tuthill M, Abraham J, Winter MC, Bye H, Hubank M, Gevensleben H, Cutts R, Snowdon C, Rea D, Cameron D, Shaaban A, Randle K, Martin S, Wilkinson K, Moretti L, Bliss JM, Ring A (2020) Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial. Lancet Oncol 21:1296\u20131308. https:\/\/doi.org\/10.1016\/s1470-2045(20)30444-7","journal-title":"Lancet Oncol"},{"key":"3846_CR32","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1200\/jco.2016.66.7162","volume":"34","author":"GR Oxnard","year":"2016","unstructured":"Oxnard GR, Thress KS, Alden RS, Lawrance R, Paweletz CP, Cantarini M, Yang JC, Barrett JC, J\u00e4nne PA (2016) Association between plasma genotyping and outcomes of treatment with osimertinib (AZD9291) in advanced non-small-cell lung cancer. J Clin Oncol 34:3375\u20133382. https:\/\/doi.org\/10.1200\/jco.2016.66.7162","journal-title":"J Clin Oncol"},{"key":"3846_CR33","doi-asserted-by":"publisher","first-page":"11815","DOI":"10.1038\/ncomms11815","volume":"7","author":"JJ Chabon","year":"2016","unstructured":"Chabon JJ, Simmons AD, Lovejoy AF, Esfahani MS, Newman AM, Haringsma HJ, Kurtz DM, Stehr H, Scherer F, Karlovich CA, Harding TC, Durkin KA, Otterson GA, Purcell WT, Camidge DR, Goldman JW, Sequist LV, Piotrowska Z, Wakelee HA, Neal JW, Alizadeh AA, Diehn M (2016) Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients. Nat Commun 7:11815. https:\/\/doi.org\/10.1038\/ncomms11815","journal-title":"Nat Commun"},{"key":"3846_CR34","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1158\/1078-0432.Ccr-10-0613","volume":"16","author":"TR Hummel","year":"2010","unstructured":"Hummel TR, Jessen WJ, Miller SJ, Kluwe L, Mautner VF, Wallace MR, L\u00e1zaro C, Page GP, Worley PF, Aronow BJ, Schorry EK, Ratner N (2010) Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin. Clin Cancer Res 16:5048\u20135057. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-10-0613","journal-title":"Clin Cancer Res"},{"key":"3846_CR35","doi-asserted-by":"publisher","first-page":"e115916","DOI":"10.1371\/journal.pone.0115916","volume":"9","author":"G Johansson","year":"2014","unstructured":"Johansson G, Peng P-C, Huang P-Y, Chien H-F, Hua K-T, Kuo M-L, Chen C-T, Lee M-J (2014) Soluble AXL: a possible circulating biomarker for neurofibromatosis type 1 related tumor burden. PLoS ONE 9:e115916\u2013e115916. https:\/\/doi.org\/10.1371\/journal.pone.0115916","journal-title":"PLoS ONE"},{"key":"3846_CR36","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1741-7015-9-82","volume":"9","author":"M Kolanczyk","year":"2011","unstructured":"Kolanczyk M, Mautner V, Kossler N, Nguyen R, K\u00fchnisch J, Zemojtel T, Jamsheer A, Wegener E, Thurisch B, Tinschert S, Holtkamp N, Park SJ, Birch P, Kendler D, Harder A, Mundlos S, Kluwe L (2011) MIA is a potential biomarker for tumour load in neurofibromatosis type 1. BMC Med 9:82. https:\/\/doi.org\/10.1186\/1741-7015-9-82","journal-title":"BMC Med"},{"key":"3846_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/1741-7015-11-109","volume":"11","author":"SJ Park","year":"2013","unstructured":"Park SJ, Sawitzki B, Kluwe L, Mautner VF, Holtkamp N, Kurtz A (2013) Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors. BMC Med 11:109. https:\/\/doi.org\/10.1186\/1741-7015-11-109","journal-title":"BMC Med"},{"key":"3846_CR38","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jdermsci.2012.04.010","volume":"67","author":"Y Yoshida","year":"2012","unstructured":"Yoshida Y, Furumura M, Tahira M, Horie T, Yamamoto O (2012) Serum biomarker in neurofibromatosis type 1. J Dermatol Sci 67:155\u2013158. https:\/\/doi.org\/10.1016\/j.jdermsci.2012.04.010","journal-title":"J Dermatol Sci"},{"key":"3846_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.62081","author":"RA Kallionp\u00e4\u00e4","year":"2021","unstructured":"Kallionp\u00e4\u00e4 RA, Ahramo K, Aaltonen M, Pennanen P, Peltonen J, Peltonen S (2021) Circulating free DNA in the plasma of individuals with neurofibromatosis type 1. Am J Med Genet Part A. https:\/\/doi.org\/10.1002\/ajmg.a.62081","journal-title":"Am J Med Genet Part A"},{"key":"3846_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124483","author":"N Eastley","year":"2020","unstructured":"Eastley N, Sommer A, Ottolini B, Neumann R, Luo JL, Hastings RK, McCulloch T, Esler CP, Shaw JA, Ashford RU, Royle NJ (2020) The circulating nucleic acid characteristics of non-metastatic soft tissue sarcoma patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21124483","journal-title":"Int J Mol Sci"},{"key":"3846_CR41","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/s41416-018-0212-9","volume":"119","author":"DS Shulman","year":"2018","unstructured":"Shulman DS, Klega K, Imamovic-Tuco A, Clapp A, Nag A, Thorner AR, Van Allen E, Ha G, Lessnick SL, Gorlick R, Janeway KA, Leavey PJ, Mascarenhas L, London WB, Vo KT, Stegmaier K, Hall D, Krailo MD, Barkauskas DA, DuBois SG, Crompton BD (2018) Detection of circulating tumour DNA is associated with inferior outcomes in Ewing sarcoma and osteosarcoma: a report from the Children\u2019s Oncology Group. Br J Cancer 119:615\u2013621. https:\/\/doi.org\/10.1038\/s41416-018-0212-9","journal-title":"Br J Cancer"},{"key":"3846_CR42","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ejca.2019.07.027","volume":"121","author":"SL George","year":"2019","unstructured":"George SL, Izquierdo E, Campbell J, Koutroumanidou E, Proszek P, Jamal S, Hughes D, Yuan L, Marshall LV, Carceller F, Chisholm JC, Vaidya S, Mandeville H, Angelini P, Wasti A, Bexelius T, Thway K, Gatz SA, Clarke M, Al-Lazikani B, Barone G, Anderson J, Tweddle DA, Gonzalez D, Walker BA, Barton J, Depani S, Eze J, Ahmed SW, Moreno L, Pearson A, Shipley J, Jones C, Hargrave D, Jacques TS, Hubank M, Chesler L (2019) A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. Eur J Cancer 121:224\u2013235. https:\/\/doi.org\/10.1016\/j.ejca.2019.07.027","journal-title":"Eur J Cancer"},{"key":"3846_CR43","doi-asserted-by":"publisher","DOI":"10.1200\/po.18.00235","author":"ML Hemming","year":"2019","unstructured":"Hemming ML, Klega KS, Rhoades J, Ha G, Acker KE, Andersen JL, Thai E, Nag A, Thorner AR, Raut CP, George S, Crompton BD (2019) Detection of circulating tumor DNA in patients with leiomyosarcoma with progressive disease. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/po.18.00235","journal-title":"JCO Precis Oncol"},{"key":"3846_CR44","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1002\/cam4.1146","volume":"6","author":"A Gutteridge","year":"2017","unstructured":"Gutteridge A, Rathbone VM, Gibbons R, Bi M, Archard N, Davies KEJ, Brown J, Plagnol V, Pillay N, Amary F, O\u2019Donnell P, Gupta M, Tirabosco R, Flanagan AM, Forshew T (2017) Digital PCR analysis of circulating tumor DNA: a biomarker for chondrosarcoma diagnosis, prognostication, and residual disease detection. Cancer Med 6:2194\u20132202. https:\/\/doi.org\/10.1002\/cam4.1146","journal-title":"Cancer Med"},{"key":"3846_CR45","doi-asserted-by":"publisher","DOI":"10.1200\/po.17.00285","author":"K Klega","year":"2018","unstructured":"Klega K, Imamovic-Tuco A, Ha G, Clapp AN, Meyer S, Ward A, Clinton C, Nag A, Van Allen E, Mullen E, DuBois SG, Janeway K, Meyerson M, Thorner AR, Crompton BD (2018) Detection of somatic structural variants enables quantification and characterization of circulating tumor DNA in children with solid tumors. JCO Precis Oncol. https:\/\/doi.org\/10.1200\/po.17.00285","journal-title":"JCO Precis Oncol"},{"key":"3846_CR46","doi-asserted-by":"publisher","first-page":"i40","DOI":"10.1093\/noajnl\/vdz047","volume":"2","author":"BC Prudner","year":"2020","unstructured":"Prudner BC, Ball T, Rathore R, Hirbe AC (2020) Diagnosis and management of malignant peripheral nerve sheath tumors: current practice and future perspectives. Neurooncol Adv 2:i40\u2013i49. https:\/\/doi.org\/10.1093\/noajnl\/vdz047","journal-title":"Neurooncol Adv"},{"key":"3846_CR47","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1097\/RLU.0b013e3182a757d3","volume":"39","author":"T Urban","year":"2014","unstructured":"Urban T, Lim R, Merker VL, Muzikansky A, Harris GJ, Kassarjian A, Bredella MA, Plotkin SR (2014) Anatomic and metabolic evaluation of peripheral nerve sheath tumors in patients with neurofibromatosis 1 using whole-body MRI and (18)F-FDG PET fusion. Clin Nucl Med 39:e301-307. https:\/\/doi.org\/10.1097\/RLU.0b013e3182a757d3","journal-title":"Clin Nucl Med"},{"key":"3846_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1002\/pbc.24212","volume":"60","author":"H Meany","year":"2013","unstructured":"Meany H, Dombi E, Reynolds J, Whatley M, Kurwa A, Tsokos M, Salzer W, Gillespie A, Baldwin A, Derdak J, Widemann B (2013) 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST). Pediatr Blood Cancer 60:59\u201364. https:\/\/doi.org\/10.1002\/pbc.24212","journal-title":"Pediatr Blood Cancer"},{"key":"3846_CR49","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008092","volume":"93","author":"S Ahlawat","year":"2019","unstructured":"Ahlawat S, Blakeley JO, Rodriguez FJ, Fayad LM (2019) Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Neurology 93:e1076","journal-title":"Neurology"},{"key":"3846_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/genes11040387","author":"DT Miller","year":"2020","unstructured":"Miller DT, Cortes-Ciriano I, Pillay N, Hirbe AC, Snuderl M, Bui MM, Piculell K, Al-Ibraheemi A, Dickson BC, Hart J, Jones K, Jordan JT, Kim RH, Lindsay D, Nishida Y, Ullrich NJ, Wang X, Park PJ, Flanagan AM (2020) Genomics of MPNST (GeM) consortium: rationale and study design for multi-omic characterization of NF1-associated and sporadic MPNSTs. Genes. https:\/\/doi.org\/10.3390\/genes11040387","journal-title":"Genes"},{"key":"3846_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan2415","author":"J Phallen","year":"2017","unstructured":"Phallen J, Sausen M, Adleff V, Leal A, Hruban C, White J, Anagnostou V, Fiksel J, Cristiano S, Papp E, Speir S, Reinert T, Orntoft MW, Woodward BD, Murphy D, Parpart-Li S, Riley D, Nesselbush M, Sengamalay N, Georgiadis A, Li QK, Madsen MR, Mortensen FV, Huiskens J, Punt C, van Grieken N, Fijneman R, Meijer G, Husain H, Scharpf RB, Diaz LA Jr, Jones S, Angiuoli S, \u00d8rntoft T, Nielsen HJ, Andersen CL, Velculescu VE (2017) Direct detection of early-stage cancers using circulating tumor DNA. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.aan2415","journal-title":"Sci Transl Med"},{"key":"3846_CR52","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature22364","volume":"545","author":"C Abbosh","year":"2017","unstructured":"Abbosh C, Birkbak NJ, Wilson GA, Jamal-Hanjani M, Constantin T, Salari R, Le Quesne J, Moore DA, Veeriah S, Rosenthal R, Marafioti T, Kirkizlar E, Watkins TBK, McGranahan N, Ward S, Martinson L, Riley J, Fraioli F, Al Bakir M, Gr\u00f6nroos E, Zambrana F, Endozo R, Bi WL, Fennessy FM, Sponer N, Johnson D, Laycock J, Shafi S, Czyzewska-Khan J, Rowan A, Chambers T, Matthews N, Turajlic S, Hiley C, Lee SM, Forster MD, Ahmad T, Falzon M, Borg E, Lawrence D, Hayward M, Kolvekar S, Panagiotopoulos N, Janes SM, Thakrar R, Ahmed A, Blackhall F, Summers Y, Hafez D, Naik A, Ganguly A, Kareht S, Shah R, Joseph L, Marie Quinn A, Crosbie PA, Naidu B, Middleton G, Langman G, Trotter S, Nicolson M, Remmen H, Kerr K, Chetty M, Gomersall L, Fennell DA, Nakas A, Rathinam S, Anand G, Khan S, Russell P, Ezhil V, Ismail B, Irvin-Sellers M, Prakash V, Lester JF, Kornaszewska M, Attanoos R, Adams H, Davies H, Oukrif D, Akarca AU, Hartley JA, Lowe HL, Lock S, Iles N, Bell H, Ngai Y, Elgar G, Szallasi Z, Schwarz RF, Herrero J, Stewart A, Quezada SA, Peggs KS, Van Loo P, Dive C, Lin CJ, Rabinowitz M, Aerts H, Hackshaw A, Shaw JA, Zimmermann BG, Swanton C (2017) Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545:446\u2013451. https:\/\/doi.org\/10.1038\/nature22364","journal-title":"Nature"},{"key":"3846_CR53","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger M, Rowan AJ, Horswell S, Math M, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald NQ, Butler A, Jones D, Raine K, Latimer C, Santos CR, Nohadani M, Eklund AC, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal PA, Swanton C (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366:883\u2013892. https:\/\/doi.org\/10.1056\/NEJMoa1113205","journal-title":"N Engl J Med"},{"key":"3846_CR54","doi-asserted-by":"publisher","first-page":"4940","DOI":"10.1038\/s41598-020-61818-1","volume":"10","author":"J Knuever","year":"2020","unstructured":"Knuever J, Weiss J, Persa OD, Kreuzer K, Mauch C, Hallek M, Schlaak M (2020) The use of circulating cell-free tumor DNA in routine diagnostics of metastatic melanoma patients. Sci Rep 10:4940. https:\/\/doi.org\/10.1038\/s41598-020-61818-1","journal-title":"Sci Rep"},{"key":"3846_CR55","doi-asserted-by":"publisher","first-page":"5017","DOI":"10.2147\/ott.S248237","volume":"13","author":"A Forschner","year":"2020","unstructured":"Forschner A, Wei\u00dfgraeber S, Hadaschik D, Schulze M, Kopp M, Kelkenberg S, Sinnberg T, Garbe C, Biskup S, Battke F (2020) Circulating tumor DNA correlates with outcome in metastatic melanoma treated by BRAF and MEK inhibitors\u2014results of a prospective biomarker study. Onco Targets Ther 13:5017\u20135032. https:\/\/doi.org\/10.2147\/ott.S248237","journal-title":"Onco Targets Ther"},{"key":"3846_CR56","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/s41591-019-0380-z","volume":"25","author":"DG Rothwell","year":"2019","unstructured":"Rothwell DG, Ayub M, Cook N, Thistlethwaite F, Carter L, Dean E, Smith N, Villa S, Dransfield J, Clipson A, White D, Nessa K, Ferdous S, Howell M, Gupta A, Kilerci B, Mohan S, Frese K, Gulati S, Miller C, Jordan A, Eaton H, Hickson N, O\u2019Brien C, Graham D, Kelly C, Aruketty S, Metcalf R, Chiramel J, Tinsley N, Vickers AJ, Kurup R, Frost H, Stevenson J, Southam S, Landers D, Wallace A, Marais R, Hughes AM, Brady G, Dive C, Krebs MG (2019) Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study. Nat Med 25:738\u2013743. https:\/\/doi.org\/10.1038\/s41591-019-0380-z","journal-title":"Nat Med"},{"key":"3846_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-1063-5","author":"Y Nakamura","year":"2020","unstructured":"Nakamura Y, Taniguchi H, Ikeda M, Bando H, Kato K, Morizane C, Esaki T, Komatsu Y, Kawamoto Y, Takahashi N, Ueno M, Kagawa Y, Nishina T, Kato T, Yamamoto Y, Furuse J, Denda T, Kawakami H, Oki E, Nakajima T, Nishida N, Yamaguchi K, Yasui H, Goto M, Matsuhashi N, Ohtsubo K, Yamazaki K, Tsuji A, Okamoto W, Tsuchihara K, Yamanaka T, Miki I, Sakamoto Y, Ichiki H, Hata M, Yamashita R, Ohtsu A, Odegaard JI, Yoshino T (2020) Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies. Nat Med. https:\/\/doi.org\/10.1038\/s41591-020-1063-5","journal-title":"Nat Med"},{"key":"3846_CR58","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1200\/jco.2017.76.8671","volume":"36","author":"JD Merker","year":"2018","unstructured":"Merker JD, Oxnard GR, Compton C, Diehn M, Hurley P, Lazar AJ, Lindeman N, Lockwood CM, Rai AJ, Schilsky RL, Tsimberidou AM, Vasalos P, Billman BL, Oliver TK, Bruinooge SS, Hayes DF, Turner NC (2018) Circulating tumor DNA analysis in patients with cancer: American Society of clinical oncology and college of American pathologists joint review. J Clin Oncol 36:1631\u20131641. https:\/\/doi.org\/10.1200\/jco.2017.76.8671","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-021-03846-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-021-03846-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T10:54:18Z","timestamp":1632999258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-021-03846-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":58,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["3846"],"URL":"https:\/\/doi.org\/10.1007\/s11060-021-03846-z","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"21 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}